Ghent, BELGIUM , Sept. 17, 2021 (GLOBE NEWSWIRE) Press release - regulated information - inside information Biotalys Board and Executive Changes Luc Basstanie retires from the Board of Directors Hilde
Home » Breaking News » Synthetic Pitch The Top Priority For Caherlohan Working Group
A general view of the senior football training pitch at The Clare GAA Centre Of Excellence in Caherlohan. Photograph by John Kelly
Synthetic Pitch The Top Priority For Caherlohan Working Group
April 29, 2021
The chairperson of the group tasked with working toward a plan to address the issues at Clare GAA’s Centre of Excellent has outlined the three main priorities to begin that process.
The much maligned €4.8 million venue at Caherlohan has been the subject of intense scrutiny and discussion over the last few months, with clubs being invited to visit the facility for themselves last weekend before making any submissions to the new strategic group for the future of Clare GAA.
Biotalys appoints new chairman of the board freshplaza.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from freshplaza.com Daily Mail and Mail on Sunday newspapers.
–
Biotalys, an AgTech company focused on addressing food protection challenges to enable a more sustainable and safer food supply, is pleased to announce the appointment of Simon Moroney as Chairman of the Board, following the Company’s Annual General Meeting end of last week.
Simon brings over 30 years of industry leadership and research experience to the Biotalys Board. From 1992 to 2019, he was co-founder and CEO of MorphoSys, a leading biotechnology company focused on the treatment of cancer and autoimmune diseases. At MorphoSys, Simon played a central role in establishing the company as a driving force in the field of therapeutic antibodies and led the company to a $239m initial public offering on the Nasdaq stock exchange in 2018. He currently sits on the board of Novartis as a non-executive Director. Simon has been recognized and awarded with the German Cross of the Order of Merit for his work and contribution to the biotechnology industry.